Company Filing History:
Years Active: 2024
Title: Nicolaï Wagtmann: Innovator in Cancer Treatment
Introduction
Nicolaï Wagtmann is a prominent inventor based in Concord, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic regimens.
Latest Patents
Wagtmann holds a patent for "Treatment regimens using anti-NKG2A antibodies." This invention relates to methods for treating diseases, particularly cancer, by using antibodies that specifically bind and inhibit human NKG2A. The patent includes therapeutic regimens designed to enhance the efficacy of anti-NKG2A antibodies.
Career Highlights
Wagtmann is associated with Innate Pharma, a company dedicated to developing innovative immunotherapies for cancer treatment. His work focuses on advancing the understanding and application of immune-based therapies.
Collaborations
He collaborates with notable colleagues, including Pascale Andre and Mathieu Blery, to further enhance the research and development efforts in the field of cancer immunotherapy.
Conclusion
Nicolaï Wagtmann's contributions to cancer treatment through his patented methods and collaborative efforts highlight his role as an influential inventor in the medical field. His work continues to pave the way for innovative therapies that may improve patient outcomes.